SOLLUM UNVEILS AN INNOVATIVE NEW RANGE OF PRODUCTS AND SERVICES ON THE EVE OF ITS 10TH ANNIVERSARY
NEW DYNAMIC LED FIXTURE AND SUNAAS® FUNCTIONALITY PACKAGES FOR GREATER CONTROL AND FLEXIBILITY MONTRÉAL, Sept. 17, 2024 /PRNewswire/ – On the eve of the 10th anniversary of its foundation in January 2015, Sollum Technologies is proud to launch new products and services built on its extensi
Skycorp’s ARMAS Sensor to Fly Aboard Lonestar Data Holding’s Freedom Payload on Intuitive Machines’ Lunar Mission to the South Pole
Pioneering Radiation Data Collection in Cislunar Space and on the Lunar Surface ST PETERSBURG, Fla. and MOUNTAIN VIEW, Calif., Sept. 17, 2024 /PRNewswire/ — SpaceBilt Inc. is proud to announce that its cutting-edge ARMAS (Automated Radiation Measurement for Aerospace Safety) sensor will be fly
Husky Labels Installs Epson SurePress L-6534VW UV Digital Label Press for Expanded Output Versatility and Improved Productivity
Indiana-Based Printing Company Combines 33 Years of Experience to Launch Printshop Touting SurePress Printing Technology LOS ALAMITOS, Calif., Sept. 17, 2024 /PRNewswire/ — Epson today announced Husky Labels in Indiana has installed the SurePress® L-6534VW UV digital label press. After decade
Metro Bank Forges Strategic Collaboration with Infosys to Accelerate Digital Transformation
To enhance digital capabilities, improve automation, refine data, and embed further AI capabilities LONDON, Sept. 17, 2024 /PRNewswire/ — Metro Bank, the UK’s community bank, has entered into a long-term collaboration with Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in
GoDaddy: AI Essentials For Small Businesses to Drive Growth and Save Time
ISLAMABAD, Sept. 17, 2024 /PRNewswire/ — Generative AI (Artificial Intelligence) is not new, however the recent boom in AI tools available to anyone such as image-generation tools and AI-driven applications, while offering new opportunities, can also place small business owners in new and unfa
Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity
– ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity – ASC30 is two- to threefold more potent, in vitro, than orforglipron and stimulated significantly greater insulin secretion
Ureteral Access Sheath Market to Reach $2.2 Billion, Globally, by 2033 at 5.5% CAGR: Allied Market Research
The ureteral access sheath market is driven by the rising prevalence of urological disorders, such as kidney stones and ureteral strictures, which necessitate endoscopic procedures. Ureteral access sheaths are used during these procedures to facilitate easy insertion and removal of medical devices,
Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference
OSLO, Norway, Sept. 17, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that international multicenter Phase III clinical trial data for its non-surgical treatment for cervical HSI
Akamai Finds Geopolitical Tensions Driving Surge in DDoS Attacks on Financial Institutions
Financial services is also most at risk for phishing and brand impersonation CAMBRIDGE, Mass., Sept. 17, 2024 /PRNewswire/ — Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, today released a new State of the Internet (SOTI) report that shows fi
Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation Compound MT1980
MANCHESTER, England, Sept. 17, 2024 /PRNewswire/ — Monument Therapeutics, a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology, today announced that the United Kingdom Intellectual Property Office (“IPO”) has granted UK
